 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              Sun Pharma Advanced Research Company Ltd has announced that pursuant to clause 10.2 of the Scheme of Arrangement for Demerger sanctioned by the Honourable High Court of Gujarat vide its order dated March 01, 2007 issued on March 28, 2007 and as per the Supplementary Trust Deed dated May 18, 2007, entered into by the Company with Sun Pharmaceutical Industries Ltd and Citicorp Trustee Co. Ltd, the Foreign Currency Convertible Bond holders of Sun Pharmaceutical Industries Ltd (SPIL), are entitled to One Equity Share of Re 1/- each of the Company for every Equity Share of Rs 5/- each of SPIL allotted to them on exercise of conversion option of Foreign Currency Convertible Bonds (FCCBs) of US$1000 each held by them.
Accordingly, the Committee of Directors (Allotment) of the Company at its meeting held July 21, 2007 has allotted 842,430 Equity Shares of Re 1/- each to the bondholders of SPIL upon exercise of option of conversion for 13,650 Zero Coupon Foreign Currency Convertible Bonds of (US $ 1000 each (FCCB) of SPIL held by them.
Consequently, The paid up Equity Share Capital of the Company has increased from 19,70,95,539 Equity Shares of Re 1/- each to 19,79,37,969 Equity Shares of Re 1/- each, as of date.